Berkshire Health Systems
  • Coronavirus Information Kiosk
  • Berkshire Patient Portal
  • COVID-19 Relief Fund for Berkshire Health Systems
  • Pay Your Bill Online
  • About Us
  • Employment
  • Medical Staff Portal
  • Coronavirus Information Kiosk
  • Berkshire Patient Portal
  • BMC Parking Maps
  • Advocacy for Access
  • Berkshire Patient Portal
  • BHS Blood Drawing Stations
  • BHS Bloodmobile
  • BHS Community Benefits Implementation Plan
  • BHS News
  • BHS Privacy Practices
  • BMC Community Benefits Report FY 2018
  • Fairview Hospital FY 2018 Community Benefit Report
  • BMC Medical Interpreters
  • Community Outreach Program
  • County Health Needs Assessment
  • Financial Counseling/Ayuda Financiera
  • Helpful Patient Tools
  • Medical Interpreters at Fairview
  • MedlinePlus
  • MedlinePlus en Espanol
  • One Medical Passport
  • Pay Your Bill Online
  • Pre-Surgical Assessment
  • Request a Medical Record
  • Send a Patient Greeting
  • Wellness Works Website - For BHS Employees & Spouses
  • Worksite Wellness
Berkshire Health Systems
  • Programs & Services
    • Addiction Services
    • Anesthesiology
    • Bariatrics
    • Better Start
    • Cancer Care
    • Cardiology
    • Concussion
    • Diabetes Care
    • Emergency Care
    • Endoscopy
    • Healthy Steps
    • Home Care
    • Hospitalists
    • Kidney & Dialysis
    • Laboratory Services
    • Maternity
    • Neurology
    • Neurosurgery
    • Occupational Med
    • Orthopedics
    • Outreach
    • Pain Management
    • Pharmacy
    • Psychiatry
    • Pulmonary Care
    • Radiology
    • Rehabilitation
    • Sleep Disorders
    • Sports Medicine
    • Stroke Care
    • Surgery
    • Trauma Care
    • Travel Medicine
    • Urgent Care
    • Urology
    • Wellness
    • WIC Program
    • Women's Imaging
    • Wound Care
    • Patient & Visitor Information
    • Quality Care & Patient Safety
    • Calendar & Events
    • News
    • Maps & Directions
    • Ways to Give
    • Health Encyclopedia
    • Berkshire Medical Center, Pittsfield, MA
    • Fairview Hospital, Great Barrington, MA
    • Berkshire Visiting Nurse Association
    • BHS Survey Module
  • Locations
    • Berkshire Medical Center
    • Fairview Hospital
    • North Adams Campus of BMC
    • BMC & Fairview Physician Practices
    • Berkshire Visiting Nurse Association
    • BHS Urgent Care
    • Long Term Care
    • BHS Laboratory - Blood Drawing Stations
  • Find a Physician
  • BHS Physician Practices
  • Medical Education
    • Message from Dr. Alex Sabo
    • Internal Medicine Residency
    • Surgery Residency
    • Osteopathic Medical Education
    • Psychiatry Residency
    • Dentistry Residency
    • Medical Students
    • Continuing Medical Education
    • School of Medical Technology
    • Schwartz Center Rounds
  • Coronavirus Information Kiosk
  • Berkshire Patient Portal
  • COVID-19 Relief Fund for Berkshire Health Systems
  • Pay Your Bill Online
  • About Us
  • Employment
  • Medical Staff Portal
S0819 -
  1. Home
  2. Clinical Trials

Clinical Trials

Principal Name   Harvey Zimbler, MD
Contact Name   Gloria Gero
Phone   (413) 496-8205
Alternate Phone   (413) 443-6000
Fax   (413) 443-2203
Title   S0819 - " A Randomized, Phase III Study Comparing Carboplatin/Paclitaxel or Carboplatin/Paclitaxel/Bevacizumab With or Without Concurrent Cetuximab in Patients with Advanced Non-Small Cel Lung Cancer (NSCLC)
Description   Primary objective of this study is:
Overall survival in the entire study popluation
Prgression-free survival by institutional review in EGFR FISH-positive patients

ARM 1
Chemoterhapy without Detuzimab =/- Bevacizumab

Arm 2
Chemotherapy with Cetuximab +/- Bevacizumab
Treatment   Oncology
Inclusion/Notes   Eligibility /Ineligibility Criteria:
-Patients must have histologically or cytologically proven primary non-small cell lung cancer (adenocarcinoma, large
cell carcinoma,k squamous or unspecified). Disease must be Stage IV. Disease may be either newly diagnosed or
recurrent after previous surgery and/or irradiaiton.
- Patients must have a CT or MRI scan of the brain to evaluate for CNS disease within 42 days prior to registration.
Patietn must not have brain metastatses unsess: 1) metastatses have been treated and have remained controlled
for at least two weeks following treatment, AND 2) patient has no residual neurological dysfunction off
corticosteroids for at least 1 day.
- Patient may have measurable or non-measurable disease docemented by CT or MRI.
-Transitional Medicine Studies: Patientsmust have tumor tissue available for submission that is sufficient for EGFR
FISH testing and must agree to submission of these specimens.
- Patients must not have received prior chemotherapy for any stage non-small cell lung cancer. Patients must not
have received prior platinnum-based chemotherapy for any purpose. Patients must not have received any
cetuzimab, gefitinib, erlotinib, or other investigational agents that target the EGFR pathway. Patients must not have
received for any purpose prior bevacizumab or other VEGF-related agents.
- Prior radiation is permitted; however, pateints must have recovered from all associated toxities at time of
registration.

- Tiome from surgical or biopsy procedures is dependent on whether it is planned for the patient to recieve bevacizumab.
- Patients must have an ANC> 1500/mcl, platelet count >100,000/mcl and hemoglobin > 9 g/dl obtained within 14 days prior to registration.
- Patients must have a serum creatinien < instttuional upper limit of normal and calculated or measured creatinine clearance > 50 cc/min using the Cockroft-Gault Formula
- For patients who will receive bevacizumab, urine protein must be screened by urine analysis for UPC ratio.
- Patients must have adequate hepatic function documented by serum bilirun,2 x ULN and either SGOT or SGPT < 2x ULN within 14 days prior to registration.
- Patients must have a Zubrdo Performance Status of 0-1
Patient must not have > Grade 2 symptomatic neuropathy-sensory
Patients must not have documented evidence of acute hpeatitis or have an active or uncontrolled infeciton.
Patients must not have the following: history(within past 6 months) of CVA, mycoaradial infarciton or unstable angina; unctontrolled hypertension.
- Patients mut be willing to provide prior smoking history
- No prior maglinancy is allowed except for the following; adequately treated basal cell or squamous cell skin cancer, ins itu cervical cancer, adequately treated Stage I or II cancer fom which the patient is currently in complete remission, or any other cancer from which teh patient has been disease free or 5 years.
- Patients must not be pregnant or nusince
-----Patients must be informed of the invbestigatinal nature of the study and must sig and give written informaed consent in accordance with institutional and federal guidelines.
Status   acccruing
Current Trial Type   treatment
  •   (413) 447-2000
  •   Email - General Inquiries Only
  •   Email - BMC Patient Experience
  •   Email - BHS Physician Practices
  •   Email - Fairview Hospital Inquiries
  • Employment at BHS
  • About Us
  • 2018 BMC Report on Cancer
  • Quality Care & Patient Safety
  • Berkshire Patient Portal
  • Awards & Accreditations
  • BHS Community Outreach
  • BHS Bloodmobile
  • BMC FY 2018 Community Benefits Report
  • Fairview FY 2018 Community Benefits Report
  • Ways to Give
  • Give Us Your Feedback

© 2021 Berkshire Health Systems

725 North Street

Pittsfield, MA 01201

  • News
  • Privacy Practices
  • Practicas De Privacidad
  • Site Map
  • BHS Privacy Practices
  • Contact Us